Sino Biological,Inc. Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Cash & Equivalents	322.3	233.35	1,316	2,380	2,872
Trading Asset Securities	2,900	3,716	3,533	3,422	3,638
Cash & Short-Term Investments	3,222	3,949	4,849	5,802	6,511
Cash Growth	-18.41%	-18.55%	-16.43%	-10.88%	476.77%
Accounts Receivable	180.22	151.44	126.33	141.08	154.07
Other Receivables	6.44	20.18	22.07	15.66	6.18
Receivables	186.66	171.63	148.4	156.74	160.25
Inventory	79.22	64.4	52.53	47.49	24.75
Prepaid Expenses	-	5.45	6.63	-	6.35
Other Current Assets	29.79	16.61	12.65	17.72	16.74
Total Current Assets	3,518	4,208	5,069	6,024	6,719
Property, Plant & Equipment	893.1	893.55	900.9	210.96	107.57
Long-Term Investments	401.13	229.17	215.94	180.24	-
Goodwill	281.93	278.38	-	-	-
Other Intangible Assets	40.2	44.79	0.8	1.11	0.92
Long-Term Deferred Tax Assets	108.05	113.81	104.63	80.28	38.26
Long-Term Deferred Charges	50.54	59.69	59.73	49	9.31
Other Long-Term Assets	250.01	227.74	249.64	34.64	15.34
Total Assets	5,543	6,055	6,601	6,580	6,890
Accounts Payable	23.72	18.21	19.33	29.23	4.25
Accrued Expenses	46.56	46.04	54.3	44.09	36.02
Current Portion of Long-Term Debt	22.42	-	-	-	-
Current Portion of Leases	-	22.47	23.37	19.81	20.45
Current Income Taxes Payable	16.25	10.3	3.05	6.76	11.94
Current Unearned Revenue	25.39	29.85	22.74	20.71	13.81
Other Current Liabilities	18.39	70.64	13.58	4.6	11.89
Total Current Liabilities	152.73	197.52	136.38	125.2	98.37
Long-Term Leases	31.1	44.9	61.69	50.65	26.9
Long-Term Unearned Revenue	10.07	2.54	4.22	5.63	-
Long-Term Deferred Tax Liabilities	34.11	36.84	31.41	29.64	12.65
Total Liabilities	228	281.8	233.7	211.11	137.92
Common Stock	121.64	121.64	129.2	129.2	68
Additional Paid-In Capital	4,354	4,353	4,796	4,793	4,853
Retained Earnings	839.79	1,300	1,434	1,432	1,809
Comprehensive Income & Other	-0.65	-1.48	7.97	14.51	22.11
Shareholders' Equity	5,315	5,773	6,367	6,369	6,752
Total Liabilities & Equity	5,543	6,055	6,601	6,580	6,890
Total Debt	53.52	67.37	85.06	70.46	47.36
Net Cash (Debt)	3,169	3,882	4,764	5,732	6,463
Net Cash Growth	-18.38%	-18.51%	-16.89%	-11.32%	472.58%
Net Cash Per Share	26.05	30.34	36.87	50.32	60.03
Filing Date Shares Outstanding	121.62	121.64	129.2	129.2	129.2
Total Common Shares Outstanding	121.62	121.64	129.2	129.2	129.2
Working Capital	3,365	4,010	4,933	5,899	6,620
Book Value Per Share	43.70	47.46	49.28	49.30	52.26
Tangible Book Value	4,993	5,450	6,366	6,368	6,751
Tangible Book Value Per Share	41.05	44.80	49.27	49.29	52.26
Buildings	-	637.92	637.92	-	-
Machinery	-	300.85	268.29	200.86	105.49
Construction In Progress	-	44.49	8.55	-	-

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.